 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Novartis Research Group Aims to Use NGS, Other Technologies to Develop Personalized Cancer Dx
August 08, 2012
Novartis Research Group Aims to Use NGS, Other Technologies to Develop Personalized Cancer Dx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Foundation Medicine, Novartis Ink New Deal for Clinical Oncology Programs
June 7, 2012 / GenomeWeb Daily News - Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News - Foundation Medicine, MSKCC to Develop Sequencing-based Blood Cancer Test from DNA, RNA
May 8, 2013 / Clinical Sequencing News - Myriad Partners with RainDance for Front End of NGS-based Hereditary Cancer Panel Test
April 17, 2013 / Clinical Sequencing News - At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News